# Derivation of Generalized Equations for the Predictive Value of Sequential Screening Tests

Using Bayes' Theorem, we derive generalized equations to determine the positive and negative predictive value of screening tests undertaken sequentially. Where a is the sensitivity, b is the specificity, ϕ is the pre-test probability, the combined positive predictive value, ρ(ϕ), of n serial positive tests, is described by: ρ(ϕ) = ϕ∏_i=1^na_n/ϕ∏_i=1^na_n+(1-ϕ)∏_i=1^n(1-b_n) If the positive serial iteration is interrupted at term position n_i-k by a conflicting negative result, then the resulting negative predictive value is given by: ψ(ϕ) = [(1-ϕ)b_n-]∏_i=b_1+^b_(n-1)+(1-b_n+)/[ϕ(1-a_n-)]∏_i=a_1+^a_(n-1)+a_n++[(1-ϕ)b_n-]∏_i=b_1+^b_(n-1)+(1-b_n+) Finally, if the negative serial iteration is interrupted at term position n_i-k by a conflicting positive result, then the resulting positive predictive value is given by: λ(ϕ)= ϕ a_n+∏_i=a_1-^a_(n-1)-(1-a_n-)/ϕ a_n+∏_i=a_1-^a_(n-1)-(1-a_n-)+[(1-ϕ)(1-b_n+)]∏_i=b_1-^b_(n-1)-b_n- The aforementioned equations provide a measure of the predictive value in different possible scenarios in which serial testing is undertaken. Their clinical utility is best observed in conditions with low pre-test probability where single tests are insufficient to achieve clinically significant predictive values and likewise, in clinical scenarios with a high pre-test probability where confirmation of disease status is critical.

## Authors

• 4 publications
• ### Bayesian Updating and Sequential Testing: Overcoming Inferential Limitations of Screening Tests

Bayes' Theorem confers inherent limitations on the accuracy of screening...
06/20/2020 ∙ by Jacques Balayla, et al. ∙ 0

• ### The Stochastic Score Classification Problem

Consider the following Stochastic Score Classification Problem. A doctor...
06/27/2018 ∙ by Dimitrios Gkenosis, et al. ∙ 0

• ### Prevalence Threshold and the Geometry of Screening Curves

The relationship between a screening tests' positive predictive value, ρ...
05/31/2020 ∙ by Jacques Balayla, et al. ∙ 0

• ### More testing or more disease? A counterfactual approach to explaining observed increases in positive tests over time

Observed gonorrhea case rates (number of positive tests per 100,000 indi...
03/26/2019 ∙ by Jessica G. Young, et al. ∙ 0

• ### Is Group Testing Ready for Prime-time in Disease Identification?

Large scale disease screening is a complicated process in which high cos...
04/09/2020 ∙ by Gregory Haber, et al. ∙ 0

• ### Optimization of Ensemble Supervised Learning Algorithms for Increased Sensitivity, Specificity, and AUC of Population-Based Colorectal Cancer Screenings

Over 150,000 new people in the United States are diagnosed with colorect...
08/13/2017 ∙ by Anirudh Kamath, et al. ∙ 0